HLA-C and neoplasm: Loss of heterozygosity and genetic deficiencies of β2-microglobulin (B2M) are both crucial ways that lead to the loss of MHC molecules (140–142), which promote resistance to PD-1 blockade due to the inability of CD8+T cells to recognize tumor antigens and specifically kill tumor cells (143).